Urgent needs to accelerate the race for COVID-19 therapeutics
EClinicalMedicine
.
2021 May 23:36:100911.
doi: 10.1016/j.eclinm.2021.100911.
eCollection 2021 Jun.
Authors
Carolina Batista
1
,
Shmuel Shoham
2
,
Onder Ergonul
3
,
Peter Hotez
4
,
Maria Elena Bottazzi
4
,
J Peter Figueroa
5
,
Sarah Gilbert
6
,
Mayda Gursel
7
,
Mazen Hassanain
8
,
Gagandeep Kang
9
,
David Kaslow
10
,
Jerome H Kim
11
,
Bhavna Lall
12
,
Heidi Larson
13
,
Denise Naniche
14
,
Timothy Sheahan
15
,
Annelies Wilder-Smith
13
16
,
Samba O Sow
17
18
,
Prashant Yadav
19
20
21
,
Nathalie Strub-Wourgaft
16
22
Affiliations
1
Médecins Sans Frontières, Rio de Janeiro, Brazil.
2
Johns Hopkins University School of Medicine, Baltimore, MD, USA.
3
Koc University Research Center for Infectious Diseases, Istanbul, Turkey.
4
Texas Children's Center for Vaccine Development, Baylor College of Medicine, Houston, TX, USA.
5
University of the West Indies, Mona, Kingston, Jamaica.
6
Jenner Institute, Nuffield Department of Medicine, Oxford University, Oxford, UK.
7
Middle East Technical University, Ankara, Turkey.
8
College of Medicine, King Saud University, Riyadh, Saudi Arabia.
9
Christian Medical College, Vellore, India.
10
Program for Appropriate Technology in Health (PATH) Essential Medicines, PATH Seattle, WA, USA.
11
International Vaccine Institute, Seoul, South Korea.
12
University of Houston College of Medicine, Houston, TX, USA.
13
London School of Hygiene & Tropical Medicine, London, UK.
14
ISGlobal-Barcelona Institute for Global Health-Hospital Clinic-University of Barcelona, Spain.
15
University of North Carolina, Gillings School of Global Public Health, Chapel Hill, NC, USA.
16
Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany.
17
Center for Vaccine Development, Bamako, Mali.
18
University of Maryland, MD, USA.
19
Center for Global Development, Washington, DC, USA.
20
Harvard Medical School, Boston, MA, USA.
21
Affiliate Professor, Technology and Operations Management, INSEAD.
22
Drugs for Neglected Diseases Initiative, Geneva, Switzerland.
PMID:
34036254
PMCID:
PMC8141354
DOI:
10.1016/j.eclinm.2021.100911
No abstract available